Sharechat Logo

Blis Technologies cuts guidance with projected 2018 loss after weaker first half

Friday 27th October 2017

Text too small?

Probiotics maker Blis Technologies won't deliver its maiden profit in 2018 as previously forecast after a weaker first half.

In July, the Dunedin-based company forecast it would post its first profit in the current year. Today, it downgraded those expectations, saying it expects revenue for the year to be similar to that of 2017, with a small positive earnings before interest, tax, depreciation and amortisation, and a net deficit.

The downturn is due to a 46 percent drop in first half sales to $2 million from $3.8 million a year earlier. Trading was weaker as sales in the first half of 2017 included "significant stock build" by its distributors in Japan and the US, but those distributors bought less stock this year, Blis said in a statement. It will post an ebitda loss of $953,000 and a pre-tax loss of $1.2 million in the first half.

The board said it anticipates a recovery in the second half.

"Contributors to this recovery include a move into the peak sales period for our products over the northern hemisphere winter, new customer launches in several markets and a return to normal ordering patterns following a correction in stock holding within the supply chain," Blis said. "The company has invested in revising the finished product portfolio and upgrading its marketing collateral, including the company's online presence. This puts the company in a stronger position to progress plans for finished product launches into key new markets, including expanding its online sales efforts internationally."

In August, chief financial officer Tim Mepham stepped down. At the time, Blis said Mepham would leave "in the coming months to pursue other business interests" and it was searching for a full-time replacement. 

Blis had previously forecast a profit for the 2017 financial year but warned the market in February this year that pre-tax profit wasn't going to meet the $700,000 forecast due to significant reductions in purchases by three major customers.

The stock last traded at 2.8 cents and has shed 30 percent this year.

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Stanley-Tallwood liquidator cuts deal over KiwiBuild development
Stanley-Tallwood liquidator cuts deal over KiwiBuild development
RBNZ expected to keep OCR at 1% but leave door open to more easing
Watch for signs of domestic and global corporate health this week
ANALYSIS: Govt will have to pay up for high-rise and other construction
23rd September 2019 Morning Report
RBNZ needs more resources, not more powers: Bascand
NZ dollar hovers near 4-yr low after IMF says downside risks have increased
MARKET CLOSE: NZ shares gain; index reweighting drives heavy trading in Kiwi, Kathmandu
NZ dollar sags after avalanche of data and central bank action

IRG See IRG research reports